A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

As many as 600,000 people could die over the next 10 years in South Africa alone as a result of U.S. funding cuts, study says ...

A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Sarah Macadam, chief executive of Thames Valley Positive Support, expects the A&E testing will lead to an increase in demand ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Human Immunodeficiency Virus, or HIV, swept through the nation ... the first successful agent in reducing the spread of HIV, new cases started to reduce. But all these years later, HIV and other ...